Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by progressive loss of photoreceptors and eventually leads to retina degeneration and atrophy. Until now, the exact pathogenesis and etiology of this disease has not been clear, and many approaches for RP therapies hav...
Main Authors: | Yuxi He, Yan Zhang, Xin Liu, Emma Ghazaryan, Ying Li, Jianan Xie, Guanfang Su |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/8/14456 |
Similar Items
-
Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
by: Leila Satarian, et al.
Published: (2017-01-01) -
Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results
by: Emin ÖZMERT, et al.
Published: (2020-01-01) -
Stem cells set their sights on retinitis pigmentosa
by: Jeannette L Bennicelli, et al.
Published: (2013-08-01) -
Effect of transplanted PEDF-hUCMSCs in the treatment of retinitis pigmentosa in rats
by: Hui Wen, et al.
Published: (2018-08-01) -
Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa
by: Aekkachai Tuekprakhon, et al.
Published: (2021-01-01)